Efficient Vascular and Neural Engraftment of Stem Cell–Derived Islets

Author:

Thorngren Julia1,Brboric Anja1,Vasylovska Svitlana1,Hjelmqvist Daisy1,Westermark Gunilla T.1,Saarimäki-Vire Jonna2,Kvist Jouni2,Balboa Diego2,Otonkoski Timo23,Carlsson Per-Ola14,Lau Joey1ORCID

Affiliation:

1. 1Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden

2. 2Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland

3. 3Children’s Hospital, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

4. 4Department of Medical Sciences, Uppsala University, Uppsala, Sweden

Abstract

Pluripotent stem cell–derived islets (SC-islets) have emerged as a new source for β-cell replacement therapy. The function of human islet transplants is hampered by excessive cell death posttransplantation; contributing factors include inflammatory reactions, insufficient revascularization, and islet amyloid formation. However, there is a gap in knowledge of the engraftment process of SC-islets. In this experimental study, we investigated the engraftment capability of SC-islets at 3 months posttransplantation and observed that cell apoptosis rates were lower but vascular density was similar in SC-islets compared with human islets. Whereas the human islet transplant vascular structures were a mixture of remnant donor endothelium and ingrowing blood vessels, the SC-islets contained ingrowing blood vessels only. Oxygenation in the SC-islet grafts was twice as high as that in the corresponding grafts of human islets, suggesting better vascular functionality. Similar to the blood vessel ingrowth, reinnervation of the SC-islets was four- to fivefold higher than that of the human islets. Both SC-islets and human islets contained amyloid at 1 and 3 months posttransplantation. We conclude that the vascular and neural engraftment of SC-islets are superior to those of human islets, but grafts of both origins develop amyloid, with potential long-term consequences. Article Highlights

Funder

Diabetesfonden

Stiftelsen Familjen Ernfors Fond

Wellcome Trust

Insamlingsstiftelsen Diabetes Wellness Network Sverige

Sigrid Juséliuksen Sätiö

Familjen Erling-Perssons Stiftelse

The Academy of Finland

Novo Nordisk Fonden

Barndiabetesfonden

Swedish Research Council

Publisher

American Diabetes Association

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3